About AllTrials

This author has not yet filled in any details.
So far AllTrials has created 214 blog entries.

Favourable results have more scientific impact than unfavourable results

A study published in JAMA Oncology has revealed that ‘positive’ cancer clinical trial results have a much higher scientific impact than ‘negative’ results.

A total of 94 patient studies were looked at, containing data from 46,424 trial participants. Out of these, only 28% of trials showed positive results. However, these trials were far more likely to be published in high impact journals than negative trials. […]

14th March 2016|

How institutions can audit registration and publication of clinical trials

In a world first, a clinical trial transparency audit of two major UK research institutions has been made publicly available. The study, published in BMJ Open, looked at the clinical trial registration and reporting performance of the Oxford Biomedical Research Centre (BRC), and the Oxford Musculoskeletal Biomedical Research Unit (BRU), who together received over £160m of public funds […]

9th March 2016|

Will the EMA’s guidance usher in a new era of trial transparency?

The European Medicines Agency (EMA) has published new guidance for pharmaceutical companies on how to comply with its policy on the publication of clinical data. The guidelines address how to prepare and submit clinical study reports (CSRs), including how to anonymise data, and how to identify and redact commercially confidential information.

CSRs are very long documents that contain detailed information about […]

9th March 2016|

¿Por qué IFMSA-Spain se une a AllTrials?

IFMSA-Spain aspira a ser uno de los promotores de AllTrials en su campaña en los países hispanoparlantes. A muchas personas puede que les sorprenda el por qué unos estudiantes de medicina deciden dar un paso adelante e intentar impulsar un proyecto que vela por el registro y publicación de todos los ensayos clínicos, es por […]

8th March 2016|

Sense about Science is recruiting an AllTrials campaign manager

Campaigns manager

Sense about Science is an independent campaigning charity that monitors and challenges the misrepresentation of science and scientific evidence in public life. We advocate for openness and honesty about scientific claims and findings, and mobilise the public to ask questions about science and evidence.

We are recruiting for this post to run the AllTrials campaign […]

2nd March 2016|

Study finds poor clinical trial reporting from leading academic centres

A study published in The BMJ today has found staggeringly poor levels of clinical trial reporting from 51 leading academic medical centres in the USA.

The study looked at 4,347 studies that were completed between October 2007 and September 2010, and identified trials with missing results two years after the trial completion. For the 51 institutions, the proportion of trials published ranged […]

18th February 2016|

How is transparency going at the European Medicines Agency?

A new article published in Trials reports that the European Medicines Agency’s system of releasing clinical trial documents may involve lengthy correspondence, and significant time delays.

In 2010, the European Medicines Agency (EMA) introduced a new policy to make detailed clinical trial information available on request. Between 2011 and 2015, the authors of the Trial study made 12 separate requests […]

16th February 2016|

MEPs call for faster implementation of clinical trial regulation

The Group of the Progressive Alliance of Socialists and Democrats (the S&D Group) is today calling on the European Commission to speed up implementation of the new European Clinical Trial Regulation. The S&D Group is the second largest political group in the European Parliament with 190 members from all 28 EU member states.

The call follows the recent […]

2nd February 2016|

Wellcome Trust appoints new independent review panel for clinical data sharing website

The Wellcome Trust has appointed a new independent review panel to assess applications from researchers for access to clinical trial data through the website

The website was set up by GlaxoSmithKline (GSK) in May 2013 to allow researchers to request trial data to carry out further research. Since then 12 more pharmaceutical companies have also committed to […]

26th January 2016|

British Pharmacological Society calls for transparency early in clinical research

Today, the British Pharmacological Society (BPS) has released a statement calling for greater trial transparency in the testing of new medicines. Following the recent phase 1 clinical trial catastrophe in France, the BPS recommends “release of the study design and protocol, the full Investigation Medicinal Product Dossier (IMPD) and the batch release data for such studies, […]

22nd January 2016|